Teriparatide
FDA APPROVED
Extensively Studied
Healing
Teriparatide
29
Amino acids
Molecular weight
Peptide
Type
Teriparatide is an FDA-approved anabolic bone-building agent consisting of the first 34 amino acids of parathyroid hormone. Unlike antiresorptive osteoporosis drugs that slow bone loss, teriparatide actively stimulates new bone formation. The key to its mechanism is intermittent exposure: while continuous PTH causes bone resorption, daily injections stimulate osteoblasts more than osteoclasts, resulting in net bone formation. Clinical trials show 8% spine bone density increases and 65% reduction in vertebral fractures.
Top researched benefits
Overview of Teriparatide
Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity. The intermittent daily dosing creates an 'anabolic window' where bone formation exceeds resorption. Teriparatide upregulates IGF-1 and FGF2 expression, stimulates bone formation on trabecular and cortical surfaces, and increases bone mineral density through preferential osteoblast stimulation.
Osteoporosis Fdaapproved
- FDA-approved for women with osteoporosis at high risk of fracture.
- FDA-approved for men with primary or hypogonadal osteoporosis at high risk.
- FDA-approved for men and women with osteoporosis from sustained corticosteroid use.
Bone Health Research
- Research interest in accelerating fracture healing and bone repair.
- Investigated for jawbone regeneration in dental applications.
Storage
Pen: 2-8°C refrigerated, do not freeze. Discard after 28 days
Frequency
Once daily at same time each day
Typical Dose
20mcg daily (FDA-approved dose)
Cycle Duration
Maximum 2 years lifetime treatment
Chemical Makeup
Key benefits
FDA-approved for osteoporosis treatment
Actively builds new bone (anabolic)
Increases spine bone density by 5-9%
Reduces vertebral fracture risk by 65%
Reduces nonvertebral fractures by 35%
Works differently than antiresorptive drugs
Benefits seen within 3 months
Creates 'anabolic window' for bone growth
Community interest
This peptide is still gaining traction in the community.
PTH(1-34) | Bone-Building Anabolic Peptide
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesTeriparatide Molecular Information
View the scientifc details of Teriparatide.
29
Amino Acids
Teriparatide
Asn
Asn
Position 1
Thr
Thr
Position 2
Glu
Glu
Position 3
Arg
Arg
Position 4
Met
Met
Position 5
Ile
Ile
Position 6
Asn
Asn
Position 7
Ala
Ala
Position 8
Leu
Leu
Position 9
Pyl
Pyl
Position 10
Phe
Phe
Position 11
Pro
Pro
Position 12
Ala
Ala
Position 13
Arg
Arg
Position 14
Ala
Ala
Position 15
Thr
Thr
Position 16
His
His
Position 17
Tyr
Tyr
Position 18
Arg
Arg
Position 19
Pyl
Pyl
Position 20
Ile
Ile
Position 21
Asp
Asp
Position 22
His
His
Position 23
Pyl
Pyl
Position 24
Arg
Arg
Position 25
Met
Met
Position 26
Pyl
Pyl
Position 27
Asn
Asn
Position 28
Glu
Glu
Position 29
Molecular Weight
4DaChain Length
29Amino AcidsType
PeptideTeriparatide Protocols
Teriparatide is administered as a once-daily subcutaneous injection, typically in the thigh or abdomen. It comes in pre-filled pen devices (Forteo) containing a 28-day supply. Treatment is typically limited to 2 years due to theoretical bone cancer risk from long-term use (seen only in rats at high doses).
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Osteoporosis treatment | 20 | 1 week range | SubQ (thigh or abdomen) |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Store pen refrigerated (do not freeze)
- Allow to reach room temperature before injection
- Attach new needle for each injection
- Inject subcutaneously in thigh or abdomen
- Discard pen after 28 days even if medication remains
Teriparatide Cycle
The Teriparatide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Month 1-3
- Bone formation begins; spine BMD increases
- Month 3-6
- Continued bone density improvements
- Month 6-12
- 5-9% spine BMD increase; fracture risk reduction
- Week 0-0
- Maximum benefits achieved; transition to maintenance
Dosing tools
Teriparatide Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Teriparatide
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Teriparatide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Teriparatide
- Dosing
- 20mcg daily (FDA-approved dose)
- Dosing Frequency
- Once daily at same time each day
- Cycle Duration
- Maximum 2 years lifetime treatment
- Storage
- Pen: 2-8°C refrigerated, do not freeze. Discard after 28 days
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Teriparatide interactions with other common peptides and substances.
Side effects
Contraindications
Paget's disease of bone
Prior skeletal radiation therapy
History of skeletal malignancies
Metabolic bone diseases other than osteoporosis
Pre-existing hypercalcemia
Pregnancy
Stop signs
Signs of hypercalcemia (confusion, fatigue, nausea)
Persistent bone pain
Allergic reactions
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
TeriparatideResearch References
Teriparatide is an extensively studied compound
Teriparatide
Teriparatide is an extensively studied compound
Teriparatide
Intermittent PTH exposure induces bone formation more than resorption; FDA-approved for osteoporosis.
n.d.
The effect of teriparatide therapy on bone density in men with osteoporosis
Spine BMD increased 5.9% (20mcg) and 9.0% (40mcg); femoral neck increased 1.5-2.9%.
n.d.
Teriparatide: 2.5 Years of Experience
Reduced vertebral fractures by 65% and nonvertebral fractures by 35% after 20 months.
n.d.
Parathyroid Hormone (1-84) and Teriparatide in Postmenopausal Osteoporosis
Initial formation without resorption creates 'anabolic window' for rapid bone volume increase.
n.d.